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Objective. Dobutamine stress echocardiography (DSE) provides an objective assessment of the presence and extent of
coronary artery disease. Therefore we compared cardiac outcome in patients at high-cardiac risk undergoing open or endo-
vascular repair of infrarenal AAA using preoperative DSE results.
Methods. Consecutive patients with 3 cardiac risk factors (age >70 years, angina pectoris, myocardial infarction, heart
failure, stroke, renal failure, and diabetes mellitus) undergoing infrarenal AAA repair were reviewed retrospectively. All
underwent cardiac stress testing using DSE. Postoperatively data on troponin release and ECG were collected on day
1, 3, 7, before discharge, and on day 30. The main outcome measures were perioperative myocardial damage and myocardial
infarction or cardiovascular death.
Results. All 77 patients (39 endovascular, 38 open) had a history of cardiac disease. The number and type of cardiac risk
factors were similar in both groups. Also DSE results were similar: 55 vs 56%, 24 vs 28%, and 21 vs 18% had no, limited,
or extensive stress induced myocardial ischemia respectively. The incidence of perioperative myocardial damage (47% vs
13%, p¼ 0.001) and the combination of myocardial infarction or cardiovascular death (13% vs 0%, p¼ 0.02) was
significantly lower in patients receiving endovascular repair.
Conclusion. In patients with similar high cardiac risk, endovascular repair of infrarenal aortic aneurysms is associated
with a reduced incidence of perioperative myocardial damage.
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Patients scheduled for abdominal aortic aneurysm re-
pair with multiple cardiac risk factors are at increased
risk of perioperative cardiac events. The incidence of
adverse perioperative cardiac complications ranges
from 1.1% to 2.4% and 9.9% for patients with no,
1 or 2, and 3 clinical cardiac risk factors.1 While car-
dioprotective medication, i.e. beta-blocker and statin
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tive cardiac events in most vascular surgery patients,
those at highest risk do not seem to benefit.1 In addi-
tion, more aggressive therapy, i.e. prophylactic coro-
nary revascularization, did not show a reduction in
perioperative adverse cardiac events in those at
high-risk.2
A major improvement for these patients at high
cardiac risk might be expected from endovascular an-
eurysm repair. However, no randomized trials com-
paring open and endovascular treatment have been
reported on patients at high cardiac risk. Less than
half of the patients in the DREAM trial (44%) and
EVAR-1 trial (43%) had a history of cardiac disease.3,4
A major limitation of non-randomized comparative
studies between open and endovascular surgical pro-
cedures conducted so far is the lack of objective cri-
teria for baseline cardiac condition.5 Preoperative
cardiac stress testing such as dobutamine stressrved.
545Myocardial Damage after AAA Repair in High-risk Patientsechocardiography (DSE) and nuclear imaging provide
an objective assessment of the presence and extent of
coronary artery disease.6 Therefore we conducted the
present study, in which patients with an infrarenal
aortic aneurysm were assessed preoperatively by
cardiac stress testing, to compare cardiac outcome in




The study population was composed of consecutive
patients with 3 or more cardiac risk factors, retrospec-
tively identified by screening of medical charts, who
underwent elective abdominal aneurysm repair
between January 2000 and January 2006 at a tertiary
referral center, Erasmus University Medical Center
Rotterdam, the Netherlands. The choice for either re-
pair method was at the discretion of the treating vas-
cular surgeon and was based mainly on anatomical
considerations. Open repair requiring suprarenal aor-
tic clamping or renal artery bypass were not included
in this analysis. The study was approved by the
Erasmus MC medical ethics committee.
Preoperative cardiac risk assessment
All patients were routinely screened for cardiac risk
factors, including age over 70 years, history of or pres-
ence of angina pectoris, previous myocardial infarc-
tion, heart failure, stroke, renal failure (serum
creatinine >2 mg/dl), and diabetes mellitus.1 The
presence of hypertension and chronic obstructive pul-
monary disease (COPD) was noted. A patient was
classified as having COPD at the preoperative screen-
ing visit according to symptoms and pulmonary func-
tion test (i.e. FEV1 <70% of maximal age and gender
predictive value). According to the ACC/AHA guide-
lines all patients with 3 or more risk cardiac risk fac-
tors underwent cardiac stress testing prior to surgery.7
Peri-operative medication use was noted including
ACE-inhibitors, platelet aggregation inhibitors, beta-
blockers, calcium antagonists, oral anticoagulants, di-
uretics, nitrates, and statins. Patients unable to take
medication orally perioperatively were switched to
intravenous formula. If no intravenous formula was
available, i.e. statins and ACE-inhibitors, oral medica-
tion was restarted as soon as possible after surgery.
Patients on chronic beta-blocker therapy continued
their medication. Patients without beta-blockers
started with bisoprolol 2.5 mg once a day at thepreoperative screening visit. Beta-blocker dose was
adjusted in all patients at admission to the hospital
and on the day prior to surgery to achieve a resting
heart frequency of 60e65 beats per minute. The
same dose of beta-blockers was continued postopera-
tively except in patients who were unable to take
medication orally. In these patients, the heart rate
was monitored continuously at the intensive care
unit or hourly at the ward, and intravenous metopro-
lol was administered at a dose sufficient to keep the
heart rate between 60e65 beats per minute.
Cardiac stress testing
Resting echocardiography was used to estimate the
left ventricular ejection fraction using the Simpson
rule. Cardiac stress testing was performed by dobut-
amine echocardiography as previously described.8
Myocardial stress induced ischemia was assessed us-
ing a semi-quantitative evaluation; a 5-point score in
a 17-segement model. Limited ischemia was defined
by the presence of 1e4 ischemic segments, while ex-
tensive ischemia was defined by 5 ischemic seg-
ments. The overall sensitivity of this technique for
the detection of significant coronary artery disease
(diameter stenosis greater than or equal to 50%) is re-
ported to be 95%; specificity 82% and accuracy 92%.9
Outcome
All patients were monitored for cardiac events after
abdominal aortic aneurysm repair. Twelve-lead ECG
and serum troponin-T level were systematically deter-
mined one, three, seven, and 30 days after surgery.
Outpatient follow-up was performed at 30 days if
a patient had been discharged from the hospital. All
patients had a follow-up at 30 days after surgery,
except for patients who died within 30 days.
The primary outcome of the study was the inci-
dence of perioperative myocardial damage defined
as a rise and fall in serum levels of cardiac troponin
T. Secondary outcomes included the incidence of
myocardial infarction and the combination of myocar-
dial infarction and cardiovascular death were as-
sessed. Myocardial infarction was defined as the
presence of 2 out of the following 3 criteria: (1) Char-
acteristic ischemic symptoms lasting >20 minutes, (2)
electrocardiographic changes including acute ST ele-
vation followed by appearance of Q waves or loss of
R waves, or new left bundle branch block, or new per-
sistent T wave inversion for at least 24 hours, or new
ST segment depression which persists >24 hours, and
(3) a positive troponin T, i.e. >0.10 ng/ml, or peakEur J Vasc Endovasc Surg Vol 33, May 2007
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kinase with characteristic rise and fall.10 Cardio-
vascular death was defined as any death with
a cardiovascular cause, including those deaths follow-
ing a cardiac procedure, cardiac arrest, myocardial
infarction, pulmonary embolus, stroke, or sudden
deaths not ascribed to other causes.11
Statistical analysis
Continuous data are presented as median values with
interquartile range, whereas dichotomous data are
presented as percentages. Differences in clinical char-
acteristics between patients undergoing endovascular
repair or open repair were evaluated by Wilcoxon
non-parametric tests, Chi-square tests or Fisher’s ex-
act tests, as appropriate. Differences in the incidence
of the endpoints were evaluated by a Chi-square
test. The limit of statistical significance was set at
P¼ 0.05 (two sided). All analysis was performed us-
ing the statistical software SPSS for Windows 12.0.1
(SPSS Inc., Chicago, Illinois, USA).
Results
Patient characteristics
A total of 77 patients were identified with 3 cardiac
risk factors who underwent either endovascular
(n¼ 39) or open (n¼ 38) infrarenal aortic aneurysm
repair. The number and type of cardiac risk factors
did not differ significantly between the treatment
groups (Table 1). The majority of patients (97%) re-
ceived perioperative beta-blocker therapy. Other car-
dioprotective medication use was similar in patients
with open or endovascular repair (Table 2).
Forty-five (58%) patients had a left ventricular ejec-
tion fraction of <35%, 61% in the open group and 56%
in the endovascular group (p¼ 0.82). Almost half
(45%) of the patients had stress inducible myocardial
ischemia during stress testing, 45% in the open group
and 46% in the endovascular group. Also the extent of
myocardial ischemia did not differ significantly be-
tween the open and endovascular group, 55 vs 54%,
24 vs 28%, and 21 vs 18% had no, limited, or extensive
stress- inducible myocardial ischemia respectively.
Based on these test results and at the discretion
of the treating physician 6 patients underwent pre-
operative cardiac revascularization to optimize
cardiac condition (2 in the open group and 4 in the
endovascular group).Eur J Vasc Endovasc Surg Vol 33, May 2007Outcome
Myocardial damage, i.e. a rise in serum levels of car-
diac troponin T, was found in 18 (47%) patients under-
going open repair and in 5 (13%) patients undergoing
endovascular repair (p¼ 0.001, Table 3). Five patients
with elevated cardiac troponin T levels had renal dys-
function. Importantly all of these patients had tropo-
nin concentrations of >0.10 ug/l. When these
patients are excluded, patients undergoing open re-
pair still had a significantly higher incidence of myo-
cardial ischemia compared to those undergoing
endovascular repair (44% vs 12%, p¼ 0.006).
Three (8%) patients in the open repair group died
within 30 days after surgery whereas in the endovas-
cular group all patients survived. Five (13%) in the
open group experienced a myocardial infarction
Table 1. Baseline characteristics (all patients 3 risk factors)
Open Endovascular
N¼ 38 N¼ 39
Male (%) 35 (92) 38 (97)
Age, years (SD) 73.6 (5.6) 73.3 (6.8)
Cardiac risk factors (%)
Myocardial infarction 31 (82) 32 (82)
Angina pectoris 25 (66) 27 (69)
Congestive heart failure 5 (13) 10 (25)
Diabetes mellitus 6 (16) 5 (13)
Renal insufficiency 6 (16) 7 (18)
CVA or TIA 13 (34) 9 (23)
Age >70 years 30 (79) 32 (82)
Other risk factors (%)
Hypertension 16 (42) 16 (41)
Previous CABG or PCI 14 (37) 17 (44)
COPD 17 (45) 15 (39)
BMI, mean (SD) 25.9 (3.9) 25.9 (3.7)




23 (61) 22 (56)
No ischemia 21 (55) 21 (54)
Limited ischemia 9 (24) 11 (28)
Extensive ischemia 8 (21) 7 (18)
CVA¼ cerebrovascular accident, TIA¼ transient ischemic attack,
CABG¼ coronary artery bypass graft, PCI¼ percutaneous coronary
intervention, COPD¼ chronic obstructive pulmonary disease,
BMI¼ body mass index, AAA¼ abdominal aortic aneurysm
Table 2. Perioperative medication use
Open Endovascular
N¼ 38 N¼ 39
Medical therapy (%)
Statin 25 (66) 22 (56)
Beta-blocker 37 (97) 38 (97)
Aspirin 23 (61) 23 (59)
Warfarin 4 (11) 7 (18)
ACE-inhibitor 14 (37) 13 (34)
Calcium antagonists 10 (26) 11 (29)
Diuretics 16 (42) 13 (33)
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incidence of the combined endpoint of cardiovascular
death or nonfatal MI for patients in the open group
was 13% versus 0% in the endovascular group
(p¼ 0.02). Importantly, patients with no, or only lim-
ited, stress-induced myocardial ischemia at preopera-
tive testing had a lower incidence of perioperative MI
than patients with extensive stress induced ischemia
(3% vs 21%, p¼ 0.03).
Discussion
Perioperative cardiac complications are a major cause
for morbidity and mortality in patients with multiple
cardiac risk factors undergoing abdominal aortic an-
eurysm repair. The optimal treatment for these pa-
tients is not well defined. Perioperative beta-blocker
use reduces the incidence of perioperative cardiac
complications in patients with no or limited stress
inducible myocardial ischemia at preoperative
testing.1,12 However, patients with extensive stress
inducible ischemia remain at high cardiac risk despite
beta-blocker use with a perioperative event rate of ap-
proximately 30%.1 It was hypothesized that prophy-
lactic revascularization might provide sufficient
protection in this patient group. Unfortunately, a re-
cently conducted study on prophylactic coronary
revascularization failed to show an improvement
in perioperative cardiac outcome in 510 patients
undergoing major vascular surgery.2 The current
study showed that, in patients at high-risk with simi-
lar extent of coronary artery disease, endovascular
treatment reduces the incidence of perioperative myo-
cardial complications as compared to open repair.
The low incidence of myocardial damage in endo-
vascular aneurysm repair has been described previ-
ously. Abraham et al. found a 10% incidence
of myocardial ischemia in endovascular treated
patients.13 Interestingly, in our group of patients
with a higher risk profile we found a similar incidence
of myocardial ischemia. The extent of coronary artery
disease as assessed by the number of stress inducible
Table 3. 30-day cardiac outcome
% Open Endovascular P-value
N¼ 38 N¼ 39
Positive Troponin T 18 (47) 5 (13) 0.001
Myocardial Infarction 5 (13) 0 0.02
All-cause death 3 (8) 0 0.11
CV death or MI 5 (13) 0 0.02
Length of stay
(median, range)
11 (3-123) 3 (1-32) <0.001
CV¼ cardiovascular, MI¼myocardial infarction, ICU¼ intensive
care unitischemic segments correlated well with the extent of
perioperative myocardial damage in the open repair
group, 5%, 11%, 38% myocardial infarctions for pa-
tients with no, limited, and extensive stress inducible
ischemia respectively. In the endovascular repair
group no such correlation was found. This difference
might be explained by the reduced myocardial stress
during an endovascular procedure.14 In patients un-
dergoing an endovascular procedure no aortic clamp-
ing and declamping are performed, the procedure is
done under loco-regional anesthesia, and in combina-
tion with a reduced blood loss a more hemodynamic
stable condition is achieved.15e18 Cuypers et al. also
confirmed these assumptions in an observational
study of 120 vascular patients.15 The incidence of
perioperative myocardial ischemia was compared
between 49 patients who underwent endovascular
treatment and 71 patients who underwent conven-
tional aortic surgical procedures using transesopha-
geal echocardiography and electrocardiography.
During aortic clamping and declamping in the
conventional surgery group hemodynamic instability
occurred, which was associated with a higher
incidence of myocardial ischemia.
Unfortunately endovascular repair can only be
performed in patients with a distinct aortic anatomy.
Endovascular repair of juxtarenal and suprarenal
aortic aneurysms is not common practice so far. How-
ever, technological development continues apace and
the first results of branched endografts are promising.
Recently O’Neill described the results of 119 patients
with an AAA anatomy unsuitable for conventional
endovascular repair.19 These patients were treated
with fenestrated stents. Only one (0.8%) patient died
(due to a non-cardiac cause) within 30 days after the
procedure.
In contrast, the results of the EVAR 2 trial, in which
patients deemed unfit for open repair were random-
ized for endovascular or no aneurysm repair, showed
a 30-day mortality of 9% after endovascular repair.20
The main difference between the patients in the
EVAR-2 trial and the current analysis is that patients
in our analysis were not deemed unfit for open sur-
gery. It is of interest that in contrast to the 100% of pa-
tients with a history of cardiac disease in the current
analysis, only 69% of the patients in EVAR-2 had a his-
tory of cardiac disease. Despite that, in the current
study we found no myocardial infarction or death in
the endovascular treated patients. It might be argued
that more patients in our study received cardioprotec-
tive medication; statin use 61% vs 39% in EVAR-2 and
97% of patients were on beta-blocker therapy.
Another important aspect of the comparison be-
tween endovascular and open repair of abdominalEur J Vasc Endovasc Surg Vol 33, May 2007
548 O. Schouten et al.aortic aneurysms is the long-term outcome after repair.
Though the DREAM trial and EVAR-1 trial showed
a peri-operative benefit for patients treated endovascu-
larly, both trials failed to show a benefit in overall sur-
vival after a median follow-up of respectively 1.8 and
2.9 years.3,21 In DREAM and EVAR-1 approximately
30 to 40% of late mortality was attributable to cardio-
vascular causes, not including aneurysm related
causes. This is not surprising since more than 60% of
vascular surgery patients have documented coronary
artery disease which will mainly determine adverse
late outcome.22 In addition, previously asymptomatic
patients may further progress during follow-up and
subsequently increase late mortality. Importantly, the
EVAR-2 trial results indicate that high-risk patients
who undergo endovascular repair have the same rate
of cardiovascular related deaths as patients random-
ized to no repair of their aneurysm during a median
follow-up of 2.4 years.20 Open abdominal aneurysm
repair might be considered the ultimate cardiac stress
test. If a patient survives the operation, the overall car-
diac prognosis might be not that bad. On the other
hand, this ‘‘selection’’ of frail patients does not occur
in patients who undergo endovascular repair. Conse-
quently, it might be argued that survivors of endovas-
cular aneurysm repair are generally in worse cardiac
health than survivors of open repair. Since long-term
outcome after successful repair of an abdominal aortic
aneurysm (open or endovascular) is related to under-
lying coronary artery disease, aggressive treatment is
of critical importance.23
The main limitation of the current study is that it is
not a randomized study. Patients were selected for
open or endovascular repair based on surgeon’s pref-
erence and anatomical features. It might be so that if
patients would have been randomized for open or
endovascular repair, thereby reducing the extent of
surgery in the conventional group (less challenging
anatomy), the difference in cardiac outcome might
be slightly less pronounced. However, the results of
the preoperative cardiac stress tests showed that the
two groups had similar prevalence and extent of
coronary artery disease.
In conclusion, endovascular therapy seems to be
associated with less perioperative adverse cardiac
events compared to open surgery in patients with 3 or
more cardiac risk factors, irrespective of the extent of
underlying coronary artery disease.
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